- Home
- KYMR vs SMTC Comparison
KYMR vs SMTC Comparison
Compare KYMR & SMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- SMTC
- Stock Information
- Founded
- KYMR 2015
- SMTC 1960
- Country
- KYMR United States
- SMTC United States
- Employees
- KYMR N/A
- SMTC N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- SMTC Semiconductors
- Sector
- KYMR Health Care
- SMTC Technology
- Exchange
- KYMR Nasdaq
- SMTC Nasdaq
- Market Cap
- KYMR 4.3B
- SMTC 4.3B
- IPO Year
- KYMR 2020
- SMTC N/A
- Fundamental
- Price
- KYMR $59.94
- SMTC $67.00
- Analyst Decision
- KYMR Strong Buy
- SMTC Strong Buy
- Analyst Count
- KYMR 19
- SMTC 15
- Target Price
- KYMR $66.84
- SMTC $64.87
- AVG Volume (30 Days)
- KYMR 631.1K
- SMTC 1.4M
- Earning Date
- KYMR 11-04-2025
- SMTC 11-24-2025
- Dividend Yield
- KYMR N/A
- SMTC N/A
- EPS Growth
- KYMR N/A
- SMTC N/A
- EPS
- KYMR N/A
- SMTC 0.29
- Revenue
- KYMR $43,735,000.00
- SMTC $996,476,000.00
- Revenue This Year
- KYMR $60.88
- SMTC $15.91
- Revenue Next Year
- KYMR N/A
- SMTC $9.77
- P/E Ratio
- KYMR N/A
- SMTC $223.48
- Revenue Growth
- KYMR N/A
- SMTC 22.22
- 52 Week Low
- KYMR $19.45
- SMTC $24.05
- 52 Week High
- KYMR $63.96
- SMTC $79.52
- Technical
- Relative Strength Index (RSI)
- KYMR 55.80
- SMTC 49.81
- Support Level
- KYMR $55.66
- SMTC $64.11
- Resistance Level
- KYMR $63.36
- SMTC $72.50
- Average True Range (ATR)
- KYMR 3.07
- SMTC 2.83
- MACD
- KYMR -0.37
- SMTC -0.66
- Stochastic Oscillator
- KYMR 57.78
- SMTC 39.56
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.